JP2024530047A5 - - Google Patents
Info
- Publication number
- JP2024530047A5 JP2024530047A5 JP2024508334A JP2024508334A JP2024530047A5 JP 2024530047 A5 JP2024530047 A5 JP 2024530047A5 JP 2024508334 A JP2024508334 A JP 2024508334A JP 2024508334 A JP2024508334 A JP 2024508334A JP 2024530047 A5 JP2024530047 A5 JP 2024530047A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021902500A AU2021902500A0 (en) | 2021-08-11 | Vaccine Antigen | |
| AU2021902500 | 2021-08-11 | ||
| AU2021902530A AU2021902530A0 (en) | 2021-08-13 | Vaccine Antigen | |
| AU2021902530 | 2021-08-13 | ||
| PCT/AU2022/050429 WO2023015332A1 (en) | 2021-08-11 | 2022-05-06 | Vaccine antigen |
| AUPCT/AU2022/050429 | 2022-05-06 | ||
| PCT/AU2022/050880 WO2023015352A1 (en) | 2021-08-11 | 2022-08-11 | Vaccine antigen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024530047A JP2024530047A (ja) | 2024-08-14 |
| JPWO2023015352A5 JPWO2023015352A5 (https=) | 2025-08-15 |
| JP2024530047A5 true JP2024530047A5 (https=) | 2025-08-15 |
Family
ID=85199645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508334A Withdrawn JP2024530047A (ja) | 2021-08-11 | 2022-08-11 | ワクチン抗原 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240350622A1 (https=) |
| EP (1) | EP4384604A4 (https=) |
| JP (1) | JP2024530047A (https=) |
| CN (1) | CN118043451A (https=) |
| AU (1) | AU2022326491A1 (https=) |
| WO (2) | WO2023015332A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4604995A1 (en) | 2022-10-17 | 2025-08-27 | BioNTech SE | Combination vaccines against coronavirus infection, influenza infection, and/or rsv infection |
| CN116726160B (zh) * | 2023-08-09 | 2023-10-27 | 中国医学科学院医学生物学研究所 | 新冠病毒突变体通用型疫苗cRBD的制备与应用 |
| WO2025035187A1 (en) * | 2023-08-15 | 2025-02-20 | Macfarlane Burnet Institute For Medical Research And Public Health Limited | Vaccine antigen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12194089B2 (en) * | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| MX2022009460A (es) * | 2020-02-04 | 2022-12-16 | Curevac Ag | Vacuna contra el coronavirus. |
| MX2022015132A (es) * | 2020-05-29 | 2023-03-08 | CureVac SE | Vacunas combinadas a base de acidos nucleicos. |
-
2022
- 2022-05-06 WO PCT/AU2022/050429 patent/WO2023015332A1/en not_active Ceased
- 2022-08-11 US US18/682,740 patent/US20240350622A1/en active Pending
- 2022-08-11 JP JP2024508334A patent/JP2024530047A/ja not_active Withdrawn
- 2022-08-11 CN CN202280061029.3A patent/CN118043451A/zh active Pending
- 2022-08-11 WO PCT/AU2022/050880 patent/WO2023015352A1/en not_active Ceased
- 2022-08-11 AU AU2022326491A patent/AU2022326491A1/en active Pending
- 2022-08-11 EP EP22854801.2A patent/EP4384604A4/en not_active Withdrawn